Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir Plus Lamivudine for Switch Therapy in Patients with HIV-1 Infection: A Real-World Cohort Study

Abstract Introduction Bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir plus lamivudine (DTG + 3TC) are well tolerated and effective in clinical trials. This study aimed to evaluate the safety and efficacy of these two schemes in a real-world setting and to obtain the fi...

Полное описание

Библиографические подробности

Главные авторы:	Lin Gan, Xiaoxin Xie, Yanhua Fu, Xiaoyan Yang, Shujing Ma, Linghong Kong, Chunli Song, Yebing Song, Tingting Ren, Hai Long
Формат:	Artigo
Язык:	Inglês
Опубликовано:	Adis, Springer Healthcare 2023-10-01
Серии:	Infectious Diseases and Therapy
Предметы:	HIV Integrase strand transfer inhibitor Low-level viraemia Real-world retrospective study Safety
Online-ссылка:	https://doi.org/10.1007/s40121-023-00879-x
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!